GGrantIndex
← Leaderboards

Rebecca L Aft

Washington University

$2,199,928
Attributed
$5,413,316
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $653.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,413,316 · 3

By mechanism

R01$5,153,248 · 2
R21$260,068 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Recurrence

Research focus

RecurrencePrimary NeoplasmPrognosticProspectiveMolecular ProfilingPathway InteractionsPhenotypeDetectionGenesMalignant Breast NeoplasmMolecularBone MarrowNeoplastic CellNeoplasm MetastasisBiologicalDistantBiological MarkersCohortGene ExpressionChemotherapyGene Expression ProfileCellsMetastatic ProcessResponse

Grant awards (12)

Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer$653,623
R01 · FY2025 · CA · contact PI
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer$620,943
R01 · FY2024 · CA · contact PI
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer$640,551
R01 · FY2023 · CA · contact PI
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer$640,551
R01 · FY2022 · CA · contact PI
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer$629,761
R01 · FY2021 · CA · contact PI
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS$384,803
R01 · FY2017 · CA · contact PI
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS$388,953
R01 · FY2016 · CA · contact PI
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS$392,520
R01 · FY2015 · CA · contact PI
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS$388,942
R01 · FY2014 · CA · contact PI
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS$412,601
R01 · FY2013 · CA · contact PI
Prognostic Marker Analysis of Disseminated Cancer Cells$128,488
R21 · FY2006 · CA · contact PI
Prognostic Marker Analysis of Disseminated Cancer Cells$131,580
R21 · FY2005 · CA